Sphingomyelinase and ceramidase in the intestinal tract

European Journal of Lipid Science and Technology

Volumn 109, Issue 10, 2007, Pages 987-993

  Duan, Rui Dong ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cancer; Ceramidase; Cholesterol absorption; Intestine; Sphingomyelinase

Indexed keywords

MAMMALIA;

EID: 35548930265     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200700074     Document Type: Conference Paper

References (57)

1. S. H. Zeisel, D. Char, N. F. Sheard: Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. J Nutr. 1986, 116, 50-58.
2. W. Christie, R. Noble, G. Davies: Phospholipids in milk and dairy products. J Soc Dairy Tech. 1987, 40, 10-12.
3. M. Blank, E. A. Cress, Z. L. Smith, F. Snyder: Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids. J Nutr. 1992, 122, 1656-1661.
4. A. Nilsson, R. D. Duan: Absorption and lipoprotein transport of sphingomyelin. J Lipid Res. 2006, 47, 154-171.
5. Y. A. Hannun, C. M. Linardic: Sphingolipid breakdown products: Anti-proliferative and tumor-suppressor lipids. Biochim Biophys Acta 1993, 1154, 223-236.
6. R. D. Duan: Phospholipid signals and intestinal carcinogenesis. Scand J Food Nutr. 2006, 50, 45-53.
7. L. Amigo, H. Mendoza, S. Zanlungo, J. F. Miquel, A. Rigotti, S. Gonzalez, F. Nervi: Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage. J Lipid Res. 1999, 40, 533-542.
8. 2 by sphingomyelin and annexin Vl. Biochem J. 1997, 326, 227-233.
9. D. L. Dillehay, S. K. Webb, E.-M. Schmelz, A. H. Merrill: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr. 1994, 124, 615-620.
10. E. M. Schmelz, P. C. Roberts, E. M. Kustin, L. A. Lemonnier, M. C. Sullards, D. L. Dillehay, A. H. Merrill, Jr.: Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res. 2001, 61, 6723-6729.
11. L. Nyberg, R. D. Duan, Å. Nilsson: A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. J Nutr Biochem. 2000, 11, 244-249.
12. M. Motouri, H. Matsuyama, J. Yamamura, M. Tanaka, S. Aoe, T. Iwanaga, H. Kawakami: Milk sphingomyelin accelerates enzymatic and morphological maturation of the intestine in artificially reared rats. J Pediatr Gastroenterol Nutr. 2003, 36, 241-247.
13. N. Garmy, N. Taieb, N. Yahi, J. Fantini: Interaction of cholesterol with sphingosine: Physicochemical characterization and impact on intestinal absorption. J Lipid Res. 2005, 46, 36-45.
14. R. D. Duan, T. Bergman, N. Xu, J. Wu, Y. Cheng, J. Duan, S. Nelander, C. Palmberg, A. Nilsson: Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem. 2003, 278, 38528-38536.
15. J. Wu, Y. Cheng, C. Palmberg, T. Bergman, A. Nilsson, R. D. Duan: Cloning of alkaline sphingomyelinase from rat intestinal mucosa and adjusting of the hypothetical protein XP_221184 in GenBank. Biochim Biophys Acta 2005, 1687, 94-102.
16. M. Tani, N. Okino, K. Mori, T. Tanigawa, H. Izu, M. Ito: Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases. J Biol Chem. 2000, 275, 11229-11234.
17. S. Mitsutake, M. Tani, N. Okino, K. Mori, S. Ichinose, A. Omori, H. Iida, T. Nakamura, M. Ito: Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem. 2001, 276, 26249-26259.
18. M. S. Choi, M. A. Anderson, Z. Zhang, D. B. Zimonjic, N. Popescu, A. B. Mukherjee: Neutral ceramidase gene: Role in regulating ceramide-induced apoptosis. Gene 2003, 315, 113-122.
19. L Nyberg, Å. Nilsson, P. Lundgren, R. D. Duan: Localization and capacity of sphingomyelin digestion in the rat intestinal tract. J Nutr Biochem. 1997, 8, 112-118.
20. M. Kono, J. L Dreier, J. M. Ellis, M. L Allende, D. N. Kalkofen, K. M. Sanders, J. Bielawski, A. Bielawska, Y A. Hannun, R. L. Praia: Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. J Biol Chem. 2006, 281, 7324-7331.
21. J. Wu, A. Nilsson, B. A. Jonsson, H. Stenstad, W. Agace, Y. Cheng, R. D. Duan: Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J. 2006, 394, 299-308.
22. R. D. Duan: Alkaline sphingomyelinase: An old enzyme with novel implications. Biochim Biophys Acta 2006, 1761, 281-291.
23. M. Olsson, R. D. Duan, L. Ohlsson, A. Nilsson: Rat intestinal ceramidase: Purification, properties, and physiological relevance. Am J Physiol Gastrointest Liver Physiol. 2004, 287, G929-G937.
24. R. D. Duan, Y. Cheng, H. D. Tauschel, A. Nilsson: Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: A potential implication in tumorigenesis. Dig Dis Sei. 1998, 43, 26-32.
25. J. Wu, F. Liu, A. Nilsson, R. D. Duan: Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gastrointest Liver Physiol. 2004, 287, G967-G973.
26. R. D. Duan, Y. Cheng, G. Hansen, E. Hertervig, J. J. Liu, I. Syk, H. Sjostrom, A. Nilsson: Purification, localization, and expression of human intestinal alkaline sphingomyelinase. J Lipid Res. 2003, 44, 1241-1250.
27. L. Ohlsson, C. Palmberg, R. D. Duan, M. Olsson, T. Bergman, A. Nilsson: Purification and characterization of human intestinal neutral ceramidase. Biochimie 2007, in press.
28. R. D. Duan, H. J. Verkade, Y. Cheng, R. Havinga, A. Nilsson: Effects of bile diversion in rats on intestinal sphingomyelinases and ceramidase. Biochim Biophys Acta 2007, 1771, 196-201.
29. J. Lillienau, Y. Cheng, A. Nilsson, R. D. Duan: Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat. Lipids 2003, 38, 545-549.
30. R. D. Duan, Y. Cheng, B. A. Jonsson, L. Ohlsson, A. Herbst, L. Hellstrom-Westas, A. Nilsson: Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites. Pediatr Res. 2007, 61, 61-66.
31. R. D. Duan, E. Hertervig, L Nyberg, T. Hauge, B. Sternby, J. Lillienau, A. Farooqi, A. Nilsson: Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci. 1996, 41, 1801-1806.
32. Y. Cheng, Å. Nilsson, E. Tömquist, R. D. Duan: Purification, characterization and expression of rat intestinal alkaline sphingomyelinase. J Lipid Res. 2002, 43, 316-324.
33. L. Nyberg, R. D. Duan, J. Axelsson, Å. Nilsson: Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1996, 1300, 42-48.
34. J. Wu, G. H. Hansen, A. Nilsson, R. D. Duan: Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis. Biochem J. 2005, 386, 153-160.
35. P. Lundgren, Å. Nilsson, R. D. Duan: Distribution and properties of neutral ceramidase activity in rat intestinal tract. Dig Dis Sci. 2001, 46, 765-772.
36. U. Sjöqvist, E. Hertervig, A. Nilsson, R. D. Duan, A. Ost, B. Tribukait, R. Lofberg: Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis. 2002, 8, 258-263.
37. E. Hertervig, A. Nilsson, L Nyberg, R. D. Duan: Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 1997, 79, 448-453.
38. E. Hertervig, Å. Nilsson, J. Björk, R. Hultkrantz, R. D. Duan: Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity; a key factor to the unrestrained cell proliferation. Br J Cancer 1999, 81, 232-236.
39. L Di Marzio, A. Di Leo, B. Cinque, D. Fanini, A. Agnifili, R Berloco, M. Linsalata, D. Lorusso, M. Barone, C. De Simone, M. G. Cifone: Detection of alkaline sphingomyelinase activity in human stool: Proposed role as a new diagnostic and prognostic marker of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14, 856-862.
40. E. Hertervig, A. Nilsson, Y. Cheng, R. D. Duan: Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J Cancer Res Clin Oncol. 2003,129, 577-582.
41. Y. Cheng, H. T Tauschel, Å. Nilsson, R. D. Duan: Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colon. Scand J Gastroenterol. 1999, 34, 915-920.
42. Y. Cheng, L. Ohlsson, R. D. Duan: Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br J Nutr. 2004, 91, 715-723.
43. J. Wu, Y. Cheng, A. Nilsson, R. D. Duan: Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis 2004, 25, 1327-1333.
44. M. Selzner, A. Bielawska, M. A. Morse, H. A. Rudiger, D. Sindram, Y. A. Hannun, P. A. Clavien: Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 2001, 61, 1233-1240.
45. H. Chen, E. Born, S. N. Mathur, F. C. Johlin, Jr., F. J. Field: Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. Biochem J. 1992, 286, 771-777.
46. I. Duivenvoorden, R J. Voshol, R C. Rensen, W. van Duyvenvoorde, J. A. Romijn, J. J. Emeis, L. M. Havekes, W. F. Nieuwenhuizen: Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice. Am J Clin Nutr. 2006, 84, 312-321.
47. E. R. Eckhardt, D. Q. Wang, J. M. Donovan, M. C. Carey: Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002,122, 948-956.
48. J. M. Holopainen, A. J. Metso, J. P. Mattila, A. Jutila, P. K. Kinnunen: Evidence for the lack of a specific interaction between cholesterol and sphingomyelin. Biophys J. 2004, 86, 1510-1520.
49. R. D. Duan: Potential link between sphingomyelin metabolism and colonic tumorigenesis. In: Exogenous Factors in Colonic Carcinogenesis. Eds. W. Scheppach, M. Scheurlen, Kluwer Academic Publishers, Lancaster (UK) 2003, pp 142-153.
50. F. Liu, Y. Cheng, J. Wu, H. D. Tauschel, R. D. Duan: Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett. 2006, 235, 41-146.
51. D. Andersson, A. Nilsson, R. D. Duan: Ursolic acid and other pentacyclic triterpenoids stimulate intestinal alkaline sphingomyelinase in vitro. Eur J Lipid Sci. Technol. 2006, 108, 103-108.
52. L. Di Marzio, F. R Russo, S. D'Alo, L Biordi, S. Ulisse, G. Amicosante, C. De Simone, M. G. Cifone: Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer 2001, 40,185-196.
53. Y. L. Lin, J. S. Liu, K. T. Chen, C. T. Chen, E. C. Chan: Identification of neutral and acidic sphingomyelinases in Helicobacter pylori. FEBS Lett. 1998, 423, 249-253.
54. C. J. Clarke, C. F. Snook, M. Tani, N. Matmati, N. Marchesini, Y A. Hannun: The extended family of neutral sphingomyelinases. Biochemistry 2006, 45, 11247-11256.
55. M. Ito, T. Kurita, K. Kita: A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms. J Biol Chem. 1995, 270, 24370-24374.
56. C. Mao, R. Xu, A. Bielawska, L. M. Obeid: Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity. J Biol Chem. 2000, 275, 6876-6884.
57. N. Okino, S. Ichinose, A. Omori, S. Imayama, T. Nakamura, M. Ito: Molecular cloning, sequencing, and expression of the gene encoding alkaline ceramidase from Pseudomonas aeruginosa. Cloning of a ceramidase homologue from Mycobacterium tuberculosis. J Biol Chem. 1999, 274, 36616-36622.